ADPT compared with LAB: revenue, margins and what each company keeps, and the suppliers and customers both name

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

LABStandard Biotools Inc.

Mkt capRevenueRevenue

Compare

ADPTAdaptive Biotechnologies Corp

LABStandard Biotools Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

ADPTwithLAB

×0.36co-movement · LAB on ADPT · 500d

r 0.36scale to r 0.75

Shared co-movers2with ADPTwith LAB

TXG10x Genomics, Inc.r 0.47r 0.41

PACBPacific Biosciences of California, Inc.r 0.43r 0.37

ADPT, solidLAB, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ADPTAdaptive Biotechnologies Corp

25.79▲+2.90%· post 25.79

Mkt cap$4.1BRevenue$72MQ2 FY26Revenue$277MFY25

LABStandard Biotools Inc.

0.61▼−0.25%· post 0.61

ClosedNov 3 '26

Mkt cap$239.4MRevenue$19MQ3 FY26Revenue$65MFY25

Compare

ClosedNov 3 '26

ADPTAdaptive Biotechnologies Corp

LABStandard Biotools Inc.

25.79▲+2.90%post 25.79

Price

0.61▼−0.25%post 0.61

$4.1B

Mkt cap

$239.4M

Q2 FY26$72M

Revenue

$19MQ3 FY26

FY25$277M

Revenue

$65MFY25

ADPT25.79▲+2.90%vsLAB0.61▼−0.25%ClosedNov 3 '26